1. IL-10 Polymorphisms and Haplotypes Predict Susceptibility to Hepatocellular Carcinoma Occurrence in Patients with Hepatitis C Virus Infection from Northeast India
   Prajjalendra Barooah et al, 2020, Viral Immunology CrossRef
2. Evolutionary modeling reveals enhanced mutational flexibility of HCV subtype 1b compared with 1a
   Hang Zhang et al, 2022, iScience CrossRef
3. Genetic variants in IL4RA, IL6, and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients
   Osama B. Al‐Saffar et al, 2020, Journal of Medical Virology CrossRef
4. The role of Th17 cells in viral infections
   Parisa Shiri Aghbash et al, 2021, International Immunopharmacology CrossRef
5. Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
   V. T. Ivashkin et al, 2023, Russian Journal of Gastroenterology, Hepatology, Coloproctology CrossRef
6. Circulating macrophage inflammatory protein-1β/IL-12p40 ratio predicts sofosbuvir-based treatment outcome in HCV- genotype 4 patients
   Heba Shawky et al, 2021, Human Antibodies CrossRef
7. Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients
   Rasoul Baharlou et al, 2018, Medical Microbiology and Immunology CrossRef
8. Individual Differences in Responsiveness to Acupuncture: An Exploratory Survey of Practitioner Opinion
   David Mayor et al, 2018, Medicines CrossRef
9. Dose-Dependent Hepacivirus Infection Reveals Linkage between Infectious Dose and Immune Response
   André Gömer et al, 2022, Microbiology Spectrum CrossRef
10. Correlation of host factor with virological response to direct-acting antiviral treatment in hepatitis C patients
    Resha Dermawansyah Rusman et al, 2022, Egyptian Liver Journal CrossRef
11. Influence of Hepatitis C virus genotype and other factors on the viral load
    Kuhu Chatterjee et al, 2024, Indian Journal of Medical Microbiology CrossRef
12. Discovery of Novel Host Molecular Factors Underlying HBV/HCV Infection
    Xubo Huang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
13. Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon
    Clauvis Kunkeng Yengo et al, 2020, Heliyon CrossRef
14. Chemokines in Primary Liver Cancer
    Monika Zajkowska et al, 2022, International Journal of Molecular Sciences CrossRef
15. Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis
    Ikram Sghaier et al, 2019, Reviews in Medical Virology CrossRef
16. Machine Learning Prediction of Adenovirus D8 Conjunctivitis Complications from Viral Whole-Genome Sequence
    Kenji Nakamichi et al, 2022, Ophthalmology Science CrossRef
17. Patient outcomes in public sector hepatitis C treatment programmes: a retrospective cohort analysis across five low- and middle-income countries
    Caroline E Boeke et al, 2022, BMJ Open CrossRef
18. Effective drugs on the road to HCV elimination and a therapeutic gap to close
    David H Muljono, 2019, The Lancet Gastroenterology & Hepatology CrossRef
19. Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy
    Oleg Kurtenkov et al, 2020, Disease Markers CrossRef
20. Response of Human Liver Tissue to Innate Immune Stimuli
    Xia Wu et al, 2022, Frontiers in Immunology CrossRef
21. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy
    Stefania Farcomeni et al, 2021, Pathogens CrossRef